Pre-exposure prophylaxis (PrEP) is an HIV prevention strategy in which antiretroviral drugs are used to protect HIV-negative people from HIV infection. PrEP can prevent HIV among individuals at very high risk for becoming infected with HIV, and provides individuals, clinicians, and HIV prevention workers with another option for HIV prevention. When taken consistently, PrEP has been shown to reduce the risk of HIV infection in people who are at high risk by up to 99% according to the CDC.
Providers play an important role in responding to inquiries about PrEP from patients and community members. The resources below provide further information for providers interested in PrEP.
- Pre-exposure Prophylaxis for the Prevention of HIV Infection in the United States - 2017 Update - A Clinical Practice Guideline (CDC & US Public Health Service)
- Pre-exposure Prophylaxis for the Prevention of HIV Infection in the United States - 2017 – Clinical Providers’ Supplement (CDC & US Public Health Service)
- CA HIV PrEP Quick Clinical Guide (CDPH & AETC)
Resources for Clinicians
- PrEP FAQs (CDC)
- PEP FAQs (CDC)
- A Guide for Discussing Sexual Health with Patients (CDC)
- PrEP Assistance Program (PrEP-AP) Benefits (CDPH)
- PrEP Medication Assistance Program Application (Gilead)
- PrEP Navigation Services (The Spahr Center)
Educational Materials for Patients
Additional Resources for Clinicians
The PrEP Clinical Consultant telephone line at (855) 448-7737 or (855) HIV-PrEP is available Monday-Friday, 8am – 3pm PST.
The Pacific AIDS Education & Training Center (PAETC) offers free technical assistance and training related to PrEP and clinical practice: www.PAETC.org, e-mail: email@example.com or telephone (415) 476-6153.